The primary goal was to determine acceptable analytical targets by analyzing human hepatocyte incubation samples with higher-resolution mass spectrometry (HRMS) and to substantiate the final results in authentic urine specimens and to find out AB-FUBINACA's metabolic steadiness in human liver microsomes and in comparison hepatocyte and urine benefi